NYSE: TFXTeleflex Inc Stock
$208.30-1.80 (-0.86%)
Updated Apr 17, 2024
TFX Price
$208.30
Fair Value Price
N/A
Market Cap
$9.80B
52 Week Low
$177.63
52 Week High
$276.43
P/E
27.48x
P/B
2.21x
P/S
3.94x
PEG
0.77x
Dividend Yield
0.65%
Revenue
$2.97B
Earnings
$356.33M
Gross Margin
55.4%
Operating Margin
17.41%
Profit Margin
12%
Debt to Equity
0.7
Operating Cash Flow
$511M
Beta
0.95
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
TFX Overview
Teleflex Incorporated manufactures single-use medical devices for critical care and surgical applications. Offerings include Arrow-branded vascular catheters, anesthesia products, surgical instruments, the UroLift System for treating urinary tract symptoms, respiratory products (oxygen and aerosol therapies, and ventilation management). The company serves hospitals and healthcare providers, and home care markets. Teleflex was incorporated in 1943 and is headquartered in Wayne, PA.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TFX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TFX ($208.30) is trading above its intrinsic value of $136.82, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TFX is good value based on its earnings relative to its share price (27.48x), compared to the US market average (41.64x)
P/E vs Market Valuation
TFX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more TFX due diligence checks available for Premium users.
Be the first to know about important TFX news, forecast changes, insider trades & much more!
TFX News
Valuation
TFX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.48x
Industry
49.9x
Market
41.64x
TFX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
TFX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
TFX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.21x
Industry
3.49x
TFX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TFX price to earnings growth (PEG)
For valuing profitable companies with growth potential
TFX is good value based... subscribe to Premium to read more.
PEG Value Valuation
TFX's financial health
Profit margin
Revenue
$773.9M
Net Income
$31.1M
Profit Margin
4%
TFX's Earnings (EBIT) of $517.85M... subscribe to Premium to read more.
Interest Coverage Financials
TFX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$7.5B
Liabilities
$3.1B
Debt to equity
0.7
TFX's short-term assets ($1.41B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TFX's long-term liabilities ($2.48B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TFX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
TFX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$138.9M
Investing
-$563.5M
Financing
-$237.5M
TFX's operating cash flow ($510.64M)... subscribe to Premium to read more.
Debt Coverage Financials
TFX vs Medical Stocks
Teleflex Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.